Lam Research
LRCX
$273.49
-8.29%
Lam Research is one of the world's largest semiconductor wafer fabrication equipment manufacturers, specializing in deposition and etch processes that build up and selectively remove layers on semiconductor wafers; it also provides a substantial customer support and services business. The company holds the top market share in etch and the clear second position in deposition, making it a critical enabler for leading-edge logic and memory chipmakers including TSMC, Samsung, Intel, and Micron, with particular leverage to DRAM and NAND customers. The current investor narrative centers on Lam's role as a picks-and-shovels beneficiary of the AI infrastructure build-out, with recent headlines debating whether it could become the next $1 trillion company and noting billionaire investors adding chip-equipment names to AI portfolios. Momentum has been powerful but volatile: record Q3 revenue and earnings in April 2026 fueled a sharp rally, yet a July 'sell the news' reaction to Samsung's strong earnings and subsequent sector rotation have kept the stock in a wide, headline-driven trading range.…
LRCX
Lam Research
$273.49
Related headlines
Investment Opinion: Should I buy LRCX Today?
The synthesized recommendation is Buy, anchored by a strong buy consensus (mean 1.457 from 31 analysts) and an average target price of $373.13, implying 25.1% upside from $298.22. The core thesis is that Lam Research is a critical enabler of the AI infrastructure build-out, with a dominant etch franchise and growing deposition share, poised to benefit from sustained semiconductor equipment demand. Despite recent momentum deterioration, the long-term growth trajectory remains intact.
Supporting evidence includes: 1) Revenue growth of 23.76% YoY in Q3 2026, with sequential acceleration; 2) Net margin expansion to 31.25% from 28.19% a year ago, demonstrating operating leverage; 3) A robust balance sheet with debt-to-equity of 0.33 and ROE of 58.26%; 4) TTM free cash flow of $6.451B, funding $1.163B in buybacks and $326M in dividends in Q3 alone; and 5) A forward PE of 25.59x, which is reasonable relative to the expected EPS of $17.30 and PEG of 1.83. The implied upside to the average analyst target is 25.1%, and the stock's 158.02% one-year return underscores its long-term momentum.
The biggest risks that could invalidate the thesis are: 1) A cyclical downturn in memory and foundry capex, which would pressure revenue and margins; 2) Valuation compression if the earnings recovery disappoints, given the high trailing multiples; and 3) Competitive pressures from Applied Materials and Tokyo Electron. The rating would upgrade to a Strong Buy if the stock breaks above $438.50 (52-week high) on sustained AI capex news, and downgrade to Hold if revenue growth decelerates below 15% or if free cash flow remains weak for two consecutive quarters. Relative to its history and peers, LRCX appears fairly valued on a forward basis but carries a premium on trailing metrics; the forward PE of 25.59x is near the middle of its multi-year range, suggesting the market is pricing in optimistic but not euphoric expectations.
Sign up to view all
LRCX 12-Month Price Forecast
The forward-looking view is bullish, supported by accelerating revenue growth, expanding margins, and a strong analyst consensus. The AI infrastructure build-out provides a multi-year tailwind, and Lam's dominant position in etch and growing deposition share position it well. However, the high beta (1.859) and recent momentum deterioration (down 18.70% over three months) warrant caution. The key risk is a cyclical downturn in memory capex, which could compress multiples and earnings. I would upgrade to high confidence if the stock breaks above $438.50 on strong volume, and downgrade to neutral if revenue growth falls below 15% or if free cash flow remains weak for two consecutive quarters.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $373.13 and implied upside of +36.4% versus the current price.
Average Target
$373.13
0 analysts
Implied Upside
+36.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$290 - $500
Analyst target range
Coverage is deep and overwhelmingly constructive, with 31 analysts following Lam Research. The consensus recommendation is a strong buy (recommendation mean of 1.457 on a 1–5 scale where 1 is a strong buy), and the average price target of $373.13 implies roughly 25.1% upside from the current price of $298.22. The sentiment leans decisively bullish, reinforced by a recent cluster of reiterated positive ratings from Needham, Stifel, Mizuho, TD Cowen, Morgan Stanley, Susquehanna, Cantor Fitzgerald, B of A Securities, Wells Fargo, and Citigroup between mid-June and mid-July 2026 — notably, all ten were reiterations of existing Buy/Outperform/Overweight/Positive ratings rather than downgrades, indicating analysts have held their conviction through the recent pullback.
The target range runs from a low of $290.00 to a high of $500.00, a spread of $210, or roughly 72% of the current price — a wide dispersion that signals meaningful disagreement about the durability of the AI capex cycle. The $500 high target implies a market cap near $625 billion and assumes sustained multiple expansion alongside accelerating AI-driven equipment demand and successful execution on the $55.75 billion consensus revenue estimate; the $290 low target, essentially at the current price, prices in a cyclical slowdown, margin compression, or a memory capex pause. The fact that the low target sits below the current price while the average implies 25% upside suggests the distribution is skewed to the upside but with a fat left tail, consistent with the stock's 1.859 beta and 41.76% max drawdown. With no downgrades in the recent institutional ratings and a strong-buy consensus, the signal is bullish, but the wide target spread argues for disciplined risk management given the stock's high volatility and cyclical exposure.
Drowning in data?
Find the real signal!
Bulls vs Bears: LRCX Investment Factors
The bull case currently has stronger evidence, supported by accelerating revenue growth (23.76% YoY), expanding margins (31.25% net), a fortress balance sheet, and a strong buy consensus with 25.1% upside to the average target. However, the bear case is not without merit: the stock is highly volatile (beta 1.859), has recently underperformed (down 18.70% over three months), and trades at elevated absolute multiples (PS 22.20x, EV/EBITDA 59.08x). The single most important tension is whether the AI-driven capex cycle can sustain the earnings recovery implied by the 25.59x forward PE; if it does, the stock is undervalued, but if memory or foundry spending pauses, the high multiples offer limited downside cushion. Given the strong fundamental momentum and analyst conviction, the bull case currently holds the edge, but the wide target range ($290-$500) and high beta argue for disciplined risk management.
Bullish
- AI-driven revenue acceleration: Q3 2026 revenue of $5.841B grew 23.76% YoY, accelerating from $5.345B in Q2 and $5.324B in Q1. The system segment contributed $3.731B, up sharply from $2.111B in support, confirming that AI-related equipment demand is the primary growth engine.
- Exceptional profitability and margin expansion: Net margin reached 31.25% in Q3 2026, up from 29.82% in Q2 and 28.19% a year ago. Gross margin of 49.83% and operating margin of 35.04% are strong even by semiconductor-equipment standards, driven by operating leverage as R&D held steady at ~$583M.
- Strong analyst consensus and upside: 31 analysts rate LRCX a strong buy (mean 1.457), with an average target of $373.13 implying 25.1% upside from $298.22. Ten firms reiterated positive ratings between mid-June and mid-July 2026, showing conviction through the recent pullback.
- Robust balance sheet and cash generation: Debt-to-equity is a conservative 0.33, current ratio is 2.63, and ROE is 58.26%. TTM free cash flow is $6.451B, and the company returned $1.163B in buybacks and $326M in dividends in Q3 alone, ending with $4.767B in cash.
Bearish
- High volatility and severe drawdowns: Beta of 1.859 means LRCX is 86% more volatile than the market, and the stock has a maximum drawdown of 41.76%. A 10% SPY decline could translate into an 18-19% drop in LRCX, demanding wider stops and smaller position sizes.
- Recent momentum deterioration: Despite a 158.02% one-year gain, the stock is down 8.55% over one month and 18.70% over three months, underperforming SPY by 7.49 and 21.74 percentage points respectively. This divergence suggests a momentum unwind that could persist.
- Elevated absolute valuation multiples: Price-to-sales of 22.20x, price-to-book of 41.35x, and EV/EBITDA of 59.08x are rich. The trailing PE of 70.97x leaves little room for error if the earnings recovery implied by the forward PE fails to materialize.
- Cyclical exposure to memory and foundry capex: Lam is more exposed to memory chipmakers for DRAM and NAND, and its system segment is inherently cyclical. The wide analyst revenue estimate range of $47.69B to $62.30B reflects real uncertainty about capex timing, and any pause could sharply reduce orders.
LRCX Technical Analysis
Lam Research is in a powerful primary uptrend that has recently entered a corrective phase. The stock is up 158.02% over the past year and 61.15% year-to-date, but at $298.22 it sits roughly 32% below its 52-week high of $438.50 and about 157% above its 52-week low of $115.88, placing it at approximately 56.6% of its 52-week range. That mid-to-upper range positioning signals a stock that has given back a meaningful portion of its gains but retains substantial long-term momentum, rather than one pinned at either an overextended peak or a distressed trough. The 41.76% maximum drawdown underscores how violently this name can retrace even within a broader uptrend, so position sizing should reflect that history.
Short-term momentum has clearly decelerated and now diverges from the longer-term trend. The stock is down 8.55% over the past month and 18.70% over the past three months, even as it remains up 40.54% over six months and 158.02% over a year. This divergence — strong 1-year gains against negative 1-month and 3-month performance — suggests a momentum unwind or mean-reversion phase rather than a confirmed trend reversal, especially since the stock is still up 40.54% over six months. Relative strength confirms the recent underperformance: LRCX trails SPY by 7.49 percentage points over one month and 21.74 points over three months, even though it leads SPY by 141.80 points over one year and 49.07 points year-to-date. The most recent session was essentially flat (+0.07%, from $298.01 to $298.22), hinting at possible stabilization after the September pullback toward $288.
Key technical levels are well defined by the 52-week range. Support sits near the $288–$290 area recently tested in early September, with the 52-week low at $115.88 as the ultimate downside reference; resistance is anchored at the 52-week high of $438.50, with intermediate supply around the $340–$370 zone where the stock repeatedly stalled in July and August. A decisive breakout above $438.50 would signal renewed leadership and likely require a fresh AI-capex catalyst, while a breakdown below $288 would open the door toward the $250–$270 congestion area from late July. Volatility is a critical consideration: the beta of 1.859 means LRCX is roughly 86% more volatile than the market, so a 10% SPY drawdown could translate into an 18–19% move in this stock, demanding wider stops and smaller position sizes.
Beta
1.86
1.86x market volatility
Max Drawdown
-41.8%
Largest decline past year
52-Week Range
$117-$439
Price range past year
Annual Return
+133.8%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | -17.7% | -2.0% |
| 3m | -26.0% | +1.4% |
| 6m | +21.7% | +15.0% |
| 1y | +133.8% | +15.7% |
| ytd | +47.8% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam Research's revenue trajectory remains firmly growth-oriented but is normalizing from a torrid pace. The most recent quarter (ended 2026-03-29) delivered revenue of $5.841 billion, up 23.76% year-over-year, following $5.345 billion in Q2 and $5.324 billion in Q1, with the prior-year Q3 at $4.720 billion. Sequentially, revenue rose from $5.324 billion to $5.345 billion to $5.841 billion, an acceleration in the March quarter, and the system segment contributed $3.731 billion versus $2.111 billion from customer support and other, showing the cyclical equipment business is the primary growth engine. With analyst consensus revenue estimates averaging $55.75 billion (range $47.69 billion to $62.30 billion), the market expects the AI-driven demand cycle to sustain growth, though the wide estimate band reflects real uncertainty about memory and foundry capex timing.
Profitability is exceptional and improving. Net income in the March 2026 quarter was $1.825 billion on $5.841 billion of revenue, a 31.25% net margin, up from $1.594 billion (29.82% margin) in Q2 and $1.569 billion (29.46%) in Q1, and well above the $1.331 billion (28.19%) reported in the year-ago quarter. Gross margin was 49.83% in the latest quarter, with the trailing figure at 50.47%, while operating margin reached 35.04% and EBITDA margin was 37.10% — levels that are strong even by semiconductor-equipment standards, where 45–50% gross margins are typical for leaders. The margin expansion is being driven by operating leverage: operating income rose to $2.047 billion from $1.810 billion sequentially, even as R&D held steady at roughly $583 million, and EPS climbed to $1.46 diluted from $1.27.
The balance sheet and cash generation are robust. Debt-to-equity is a conservative 0.33, the current ratio is 2.63, and ROE is an outstanding 58.26% with ROA of 22.84%, indicating highly efficient capital deployment. Free cash flow on a trailing-twelve-month basis is $6.451 billion, and the company returned substantial capital in the March quarter alone — $1.163 billion in buybacks and $326 million in dividends — while still ending with $4.767 billion in cash. However, quarterly free cash flow of $810 million was well below the $1.665 billion generated in Q2 and the $1.594 billion in Q1, reflecting a $875 million working-capital drag and $332 million of capex, so investors should monitor whether this is a timing issue or a sign of softening collections as the cycle matures.
Quarterly Revenue
$5.8B
2026-03
Revenue YoY Growth
+23.8%
YoY Comparison
Gross Margin
49.8%
Latest Quarter
Free Cash Flow
$6.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Because Lam Research is solidly profitable — trailing net income is positive and the trailing PE is 70.97x — the PE ratio is the appropriate primary metric, though the trailing figure is distorted by a very low trailing EPS base of $0.0141 that reflects a sharp earnings trough in the trailing window. The forward PE of 25.59x is far more informative and implies the market expects a dramatic earnings recovery: consensus estimated EPS averages $17.30 (range $14.05–$19.94), which explains the enormous gap between the 70.97x trailing and 25.59x forward multiples. That gap signals the market is pricing in a full-cycle earnings normalization rather than extrapolating current depressed trailing profitability, and it makes the forward multiple the more decision-relevant anchor.
Relative to the broader semiconductor sector, LRCX screens at a premium on most metrics. Its price-to-sales ratio of 22.20x and price-to-book of 41.35x are elevated, and EV/EBITDA of 59.08x and price-to-cash-flow of 88.04x are rich, while the PEG ratio of 1.83 suggests the growth-adjusted valuation is more reasonable than the headline multiples imply. The forward PE of 25.59x is the most defensible comparison point and sits at a moderate premium to the market, which is arguably justified by a 31.25% net margin, 58.26% ROE, and a dominant etch franchise levered to AI-driven capex. The premium is a bet on continued AI infrastructure spending; if memory or foundry capex disappoints, these multiples offer limited downside cushion.
Historically, the stock's valuation has expanded dramatically. The PE ratio has climbed from 18.03x in Q4 2025 and 26.43x in Q1 2026 to 34.23x in the latest reported quarter, while the PS ratio rose from 23.99x to 42.77x over the same span — though the current market-data PS of 22.20x and forward PE of 25.59x suggest the recent 18.70% three-month price decline has already compressed multiples from their spring peaks. The current forward PE of 25.59x is near the middle-to-upper end of the stock's multi-year band (which has ranged from roughly 9x to 34x on a trailing basis), implying the market is pricing in optimistic but not euphoric expectations. The key risk is that the trailing PE of 70.97x and PB of 41.35x leave little room for error if the earnings recovery implied by the forward multiple fails to materialize.
PE
71.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
59.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but notable. The debt-to-equity ratio of 0.33 is conservative, and the current ratio of 2.63 indicates ample liquidity, but the company's revenue is heavily concentrated in the cyclical semiconductor equipment market, with the system segment contributing $3.731B of $5.841B in Q3 2026. A downturn in memory or foundry capex could rapidly reduce orders, as evidenced by the wide analyst revenue estimate range of $47.69B to $62.30B. Additionally, quarterly free cash flow dropped to $810M from $1.665B in Q2 due to an $875M working-capital drag, which could signal collection issues or inventory build if it persists.
Market and competitive risks are significant given the stock's high beta of 1.859 and premium valuation. The trailing PE of 70.97x and PS of 22.20x are elevated, leaving little room for disappointment. Competition from Applied Materials and Tokyo Electron could pressure market share, particularly in deposition where Lam holds the second position. Regulatory risks, such as export controls to China, remain a persistent overhang for semiconductor equipment makers. Recent news highlights a 'sell the news' reaction to Samsung's strong earnings in July 2026, which dragged down semiconductor stocks and signaled potential overvaluation in AI-related sectors. Sector rotation away from AI infrastructure could further compress multiples.
The worst-case scenario would involve a sharp cyclical downturn in memory and foundry capex, leading to declining orders and margin compression. In this scenario, the stock could retest its 52-week low of $115.88, representing a 61% decline from the current price of $298.22. The analyst low target of $290 is only 2.8% below the current price, but the wide target range and historical max drawdown of 41.76% suggest that a more severe selloff is possible. If AI spending decelerates and the earnings recovery implied by the forward PE fails to materialize, the stock could fall to the $200-$250 range, a loss of 16-33% from current levels. Investors should be prepared for significant drawdowns given the stock's history.
FAQ
The key risks for LRCX, ranked by severity, are: 1) Cyclical downturn in memory and foundry capex, which could sharply reduce orders and revenue, as the system segment is highly cyclical and memory customers like Samsung and Micron are major clients; 2) Valuation compression, given the high trailing PE of 70.97x and PS of 22.20x, which could lead to a sharp selloff if earnings disappoint; 3) Competitive pressures from Applied Materials and Tokyo Electron, particularly in deposition where Lam holds the second position; and 4) Macro and geopolitical risks, including export controls to China and the stock's high beta of 1.859, which amplifies market downturns. Additionally, the recent free cash flow decline to $810M in Q3 2026 from $1.665B in Q2 due to working-capital drag warrants monitoring.
The 12-month forecast for LRCX includes three scenarios: a bull case (30% probability) with a target range of $438.50-$500, driven by sustained AI capex and a breakout above the 52-week high; a base case (50% probability) with a target range of $340-$400, assuming steady execution and revenue growth of 20-25%; and a bear case (20% probability) with a target range of $200-$290, triggered by a cyclical downturn in memory and foundry spending. The base case is most likely, with the stock gradually recovering toward the analyst average target of $373.13. The key assumption is that AI infrastructure demand remains robust and Lam continues to gain share in deposition and etch. However, the wide target range reflects significant uncertainty, and investors should monitor earnings and capex trends closely.
LRCX appears fairly valued on a forward basis but carries a premium on trailing metrics. The trailing PE of 70.97x is distorted by a depressed trailing EPS of $0.014, while the forward PE of 25.59x is more informative and sits near the middle of its multi-year range. The PS ratio of 22.20x and EV/EBITDA of 59.08x are elevated compared to the broader market, but the PEG of 1.83 suggests the growth-adjusted valuation is reasonable. The market is pricing in a full-cycle earnings recovery, with consensus EPS of $17.30, implying significant growth from current levels. Relative to peers like Applied Materials, LRCX trades at a premium, justified by its dominant etch franchise and higher margins. If the AI capex cycle continues, the stock could be undervalued; if it stalls, the premium leaves little downside cushion.
From a risk/reward perspective, LRCX offers a favorable setup for investors with a long-term horizon and tolerance for volatility. The stock trades at $298.22, with a strong buy consensus and an average target of $373.13, implying 25.1% upside. The forward PE of 25.59x is reasonable given expected EPS of $17.30, and the company's 31.25% net margin and 58.26% ROE are exceptional. However, the high beta of 1.859 and recent 18.70% three-month decline highlight significant downside risk, including a potential retest of the 52-week low of $115.88 in a severe downturn. It is a good buy for growth-oriented investors who can withstand a 30-40% drawdown and hold for at least 2-3 years, but not suitable for risk-averse or short-term traders.
LRCX is more suitable for long-term investment, given its cyclical growth profile, high volatility (beta 1.859), and low dividend yield of 0.25%. The stock has delivered a 158.02% one-year return but has experienced a 41.76% max drawdown, making it unsuitable for short-term trading unless one has a high risk tolerance and active management strategy. The company's strong fundamentals, including 23.76% revenue growth, 31.25% net margin, and $6.451B TTM free cash flow, support a multi-year holding period to ride out cyclical downturns. A minimum holding period of 2-3 years is recommended to capture the AI infrastructure build-out and earnings recovery. Short-term traders could exploit volatility around earnings, but the high beta and headline-driven trading range make timing difficult.
